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A B S T R A C T
Hip arthroscopic surgery for femoroacetabular impingement and periacetabular osteotomy (PAO) for
dysplasia is the most commonly used contemporary treatment for these conditions and has been shown to
provide pain relief and restore function. What is less understood and perhaps of more interest to health
economists, is the role of these procedures in preserving the hip joint and avoiding hip arthroplasty. The aim
of this systematic review was to determine whether hip joint preservation surgery, indeed, preserves the hip
joint by looking at conversion rates to total hip arthroplasty (THA). Two separate searches were undertaken,
using PRISMA guidelines and utilizing PubMed and Open Athens search engines, identifying manuscripts
that looked at conversion to THA following either hip arthroscopy (HA) or PAO. When considering HA, we
found 64 eligible papers. Out of these studies, there were 59 430 hips with 5627 undergoing conversion to
THA (9.47% [95% CI 9.23–9.71%]) with a mean conversion time of 24.42 months. Regarding PAO, there
were 46 eligible papers including 4862 patients who underwent PAO with subsequent conversion to THA in
404 patients (8.31% [95% CI 7.54–9.12%]). with a mean conversion time of 70.11 months. Certain features
were associated with increased conversion rates, including increasing age, worsening arthritis and joint space
<2 mm. This study demonstrates that the mean conversion rates to be <10% for HA and PAO, during the
mean follow-up periods of included manuscripts. Joint preserving surgery appears to defer or at least delay
the need for THA.
I N T R O D U C T I O N
Joint arthroplasty surgery for hip pathology has a historical
track record of achieving good outcomes. With satisfaction
rates of around 90% [1], it gives predictable pain relief
and restoration of function in a large number of patients.
However, when considering the younger patient, it is par-
ticularly important to consider implant survival. We know
that around 90% of arthroplasties will survive up until
15 years [2] and around 85% will last 20 years [3] and for
this reason, the prospect of revision surgery due to im-
plant wear/failure, in elderly patients, becomes less of a
concern. However, when managing younger patients with
hip pathology, one must be acutely aware of the potential
need for revision or multiple revision surgeries, given the
increased life expectancy and potentially increased
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physical demands of someone of younger age. Therefore,
when considering the ‘young adult’ with hip pathology, it
is important to be aware of surgeries that look to provide
pain relief, restore function and preserve the native hip.
Furthermore, joint preservation surgery may have a role in
easing the economic burden associated with total hip
arthroplasty (THA).
There is an established link between untreated femo-
roacetabular impingement (FAI) and hip dysplasia and
osteoarthritis (OA) [4, 5]. The main surgeries used in the
setting of young adult hip pathology are hip arthroscopy
(HA) and periacetabular osteotomy (PAO). Arthroscopy
is frequently used for FAI surgery [6], where there is a
motion-related disorder of the hip, composed of clinical
signs and imaging findings, which results in premature
contact between the proximal femur and the acetabulum
[7]. Commonly, a cam (abnormality of the shape of
femoral head) and/or pincer (prominent acetabular rim)
lesion may be present and arthroscopy allows one to
address the intra-articular pathology, such as chondral
damage or labral tears, as necessary [8]. PAO surgery is
often utilized in situations where a patient has a degree of
adult hip dysplasia that may not have been clinically
present as a child but has subsequently become clinically
apparent later in life, or for patients who have had ongoing
sequalae of appropriately managed paediatric dysplasia.
Having been developed by Ganz [9], the aim of the PAO
is to reorient the acetabulum, reducing superolateral
acetabular inclination, improving femoral head coverage,
translating the joint centre medially and normalizing
loading of the anterolateral acetabular rim to prevent
disease progression. The aim of these procedures is 2-fold
as follows:
1. to improve pain and function, something that is
well described in the literature and [10]
2. to preserve the hip joint, which the authors feel
has not been clearly explored yet.
These surgical strategies offer a solution to young adult
hip pathology that allows joint preservation. It is recog-
nized that despite patients undergoing joint preservation
surgery, a number of patients subsequently need to go on
to have arthroplasty, which may be considered a failure of
the joint preservation surgery. However, even if patients
are to eventually undergo subsequent arthroplasty HA and
PAO may be considered successful by deferring the need
for THA until later in life.
Therefore, the aim of this paper was to determine the
incidence of conversion to THA, following hip
preservation surgery along with time to conversion, for
those who underwent subsequent THA.
M A T E R I A L S A N D M E T H O D S
Study design
This systematic review was constructed using the 2009
PRISMA [11] guidelines and relevant studies were identi-
fied by searching papers via the PubMed and Open Athens
search engines searching the AMED, Medline, CINAHL,
PubMed, HBE and OVID/Embase databases. We under-
took two separate literature reviews to look at each of these
interventions and assess their effect as joint preserving sur-
geries. The primary outcome measure we used for this lit-
erature review was looking at conversion rate to THA.
Search strategy
The searches of the aforementioned databases were last
performed in November 2018. There was no restriction to
dates where articles will be included from inception. The
search subsequently included articles from other sources
via cross-referencing that were added to the final pool of
studies.
The search strategies used were:
((hip arthroscopy)) AND ((Conversion) OR
(THA) OR (THR) OR (arthroplasty) OR (replace-
ment) OR (survival)) - for articles relating to hip
arthroscopy
((Periacetabular osteotomy) OR (Bernese osteot-
omy) OR (Ganz Osteotomy)) AND ((Conversion)
OR (THA) OR (THR) OR (arthroplasty) OR (re-
placement) OR (survival)) - for articles relating to
PAO
Study selection
Studies were the screened according to the inclusion and
exclusion criteria. Papers considered for inclusion criteria
were those that looked at outcomes for HA or PAO sur-
gery, where THA was measured as an endpoint. We
excluded articles if they were case reports, conference
abstracts or instructional papers. There were numerous
papers that were excluded due to them containing dupli-
cate datasets, however, a number of papers were included
where there was/may have been small overlap of datasets,
due to minimal overlay of study periods stated and at the
expense of not capturing relevant data, these papers were
included. We, further, excluded papers if they were looking
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at revision HA, dealt with open or combined open proce-
dures, were utilizing HA to evaluate THA, not using con-
version to THA as an endpoint, utilizing HA to evaluate or
treat symptoms post-PAO in the setting of hip dysplasia or
papers that looked at arthroscopic use of novel stem cell/
biological therapies. Data published on open management
of FAI surgery were not included as the authors felt that
the literature was too sparse and heterogeneous to include,
difficult to compare results due to lack of standardization
and because the trend in the literature is towards arthro-
scopic management of FAI. Search strategies were
reviewed by the lead author and was secondarily reviewed
by a separate author to ensure that all relevant studies were
included and to remove selection bias. If there was a dis-
crepancy or query as to whether a paper should be
included this a third opinion from one of the senior
authors was sought.
Data extraction
The selected articles underwent duplicate removal both
electronically and manually and the subsequent articles
were exported to EndnoteTM reference manager.
Following this, abstracts were reviewed in line with the in-
clusion/exclusion criteria. The final number of articles
remaining were then assessed via full-text review and data
were extracted and placed into a spreadsheet in Microsoft
ExcelTM based on a pre-determined set of variables, which
included, author, year, level of evidence, MINORS score,
number of hips included, mean age, number of hips con-
verted to THA, mean (or median) follow-up (months),
mean time to conversion (months).
Data analysis and synthesis
Papers were attributed a ‘level of evidence’ based on the
‘Oxford Centre for Evidenced-Based Medicine—levels of
evidence’ [12]—this did not always correlate with the
authors self-declaration of level of evidence.
Papers were also graded according to MINORS score
[13], where there was any ambiguity, uncertainty or insuffi-
cient information for attributing points, for the MINORS
scoring for each criteria, points were not given.
Statistical analysis
Statistical analysis on categorical data was performed using
Chi-squared test and for continuous data, student t-test
was used. Confidence intervals were obtained by using
binomial distribution calculations. Data were analysed
using MinitabV
R
18.1 statistical analysis software. A P values
of <0.05 was considered statistically significant. Data were
sub-analysed, when considering risk factors for conversion
to THA, if papers presented sufficient raw data allowing
for such sub-analysis.
R E S U L T S
In this review, papers pertaining to HA had shorter follow-
up (mean of mean follow-ups 46.41 months) compared
with PAO (mean of mean follow-ups 85.5 months), this
was statistically significant at P< 0.001.
The mean of mean time to conversion for PAO was
significantly longer than that for HA (24.42 versus
70.11 months) P< 0.001.
FAI: hip arthroscopy
Our literature search identified 1462 papers and 3 papers
were found via cross-referencing. Duplicate papers were
removed, leaving 698 papers (Fig. 1).
After review of manuscript titles and abstract, 592
papers were excluded and after review of the full-text
manuscript, a further 47 were excluded. This left a total of
62 papers [14–75].
Evidence
From the 62 papers included in our study, 1 paper of Level
2b, 5 papers of Level 3b and 57 papers of Level 4 evidence.
Mean MINORS scores for non-comparative studies
were 10 and 17 for comparative studies.
Key findings
The key findings of the studies along with outcome for
conversion rates to THA are included in Table I. Upon
analysis, there were 59 430 hips looked at with 5627 that
underwent conversion to THA, giving a percentage
conversion of 9.47% [95% CI 9.23–9.71%]. For papers
that stated mean age, the mean age from these was
40.33 years. Where papers stated their mean follow-up, in a
way that could be analysed; the range was 9.9–156 months
and this gave a mean follow-up time, for all papers of
46.41 months. Where papers stated the mean conversion
to THA in a way that could be analysed; the range was
8 months to 96 months, and this gave a mean conversion
time for all papers of 24.42 months.
While many papers made reference to the mean age of
patients and its implication on conversion, four papers [22,
34, 39, 54] presented data, related to age groups, in a way
that could be analysed. This included 256 patients. These
four papers looked to compare those under 40 years of age
versus over 40 years of age. From these four papers, there
were 29 out of 142 hips (20.4% [95% CI 14.1–28.0%])
under 40, which underwent HA and were subsequently
converted to THA, versus 47 out of 114 hips (41.2%
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[95% CI 32.1–50.83%]) of patients over 40. On statistical
analysis, this was statistically significant at P< 0.001.
Mean follow-up, for these papers, where stated, was
longer than the mean of all papers at 94.3 months versus
35.8 months and mean time to conversion was
35.8 months versus 23.8 months for all papers, this may
contribute to the higher percentage of conversion;
however, these mean values, for these papers, were not
statistically significantly different from the remaining
papers.
Four papers [13, 22, 34, 64] looked at the prevalence of
conversion to THA based on their grade of OA and pre-
sented data in a way that could be analysed. This included
235 patients. In order to standardize arthritis, the authors
categorized it as non/mild–moderate and severe, where
Outerbridge (0/1/2), Tonnis (0/1), Kellegren-Lawrence
(0/1/2)—was non/mild–moderate and Outerbridge
(3/4), Tonnis (2/3), Kellegren-Lawrence (3/4)—was se-
vere. Where authors reported more than one, Tonnis grade
was used preferentially.
From these papers, 14 out of 115 (12.17% [95% CI
6.81–19.58%])of all patients with non/mild–moderate OA
underwent conversion to THA versus 61 out of 120
(50.83% [95% CI 41.55–60.07%]) of patients with moder-
ate to severe OA. This was statistically significant at
P< 0.001.
Three papers [30, 33, 72] looked at the prevalence of
conversion to THA based on joint space narrowing and
presented data in a way that could be analysed. This
included 599 patients. Out of those with >2 mm joint
space, 84 out of 513 (16.37% [95% CI 13.28–19.87%])
underwent THA versus 69 out of 86 (80.23% [95% CI
70.25–88.04%]) of patients with a joint space of <2 mm.
This was statistically significant at P< 0.001, suggesting
reduced joint space may be a risk factor for conversion to
THA after HA.
Periacetabular osteotomy
Our literature search identified 560 papers and 10 papers
were found via cross-referencing. Duplicate papers were
removed, leaving 230 papers. After review of manuscript
titles and abstract, 162 papers were excluded and after re-
view of the full-text manuscript, a further 22 were excluded.
This left a total of 46 papers [76–119].
Fig. 1. HA search: PRISMA flowchart.
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Table I. Results for HA

















Farjo et al. 1999 4 12 28 41 6 34 14
Londers et al. 2007 4 10 56 34 7 72 27
Byrd et al. 2008 4 12 207 33 1 16 8
Ilizaliturri et al. 2008 4 11 19 34 1 Minimum 36 Not stated
Larson et al. 2008 4 12 100 34.7 3 9.9 Not stated
Kamath et al. 2009 4 12 52 42 3 57.6 8
Philppon et al. 2009 4 10 112 40.6 10 27.6 16
Gedouin et al. 2010 4 12 111 31 5 10 12
Haviv et al. 2010 4 10 564 55 90 38.4 18
Horisberger et al. 2010 4 12 19 Not stated 10 36 16.8
Mccarthy et al. 2010 4 10 111 39 49 156 57.6
Singh et al. 2010 4 10 27 22 0 22 NA
Byrd et al. 2011 4 10 200 28.6 1 19 Not stated
Byrd et al. 2011 4 12 100 34 0 10 NA
Javed et al. 2011 4 10 40 65 7 30 12
Konan et al. 2011 4 12 100 32 6 Not stated Not stated
Meftah et al. 2011 4 12 50 40.1 2 100.8 58.2a
Schilders et al. 2011 4 10 101 37 0 29.28 NA
Mccormick et al. 2012 4 8 176 40.9 20 51.6 31.2
Palmer et al. 2012 4 10 201 40.2 13 46 17.7
Bogunovic et al. 2013 4 10 1724 Not stated 60 Not stated 31
Boykin et al. 2013 4 11 23 28 2 41.1 Not stated
Geyer et al. 2013 4 12 76 38.5 19 49 28
Matsuda et al. 2013 3b 16/24 54 34.6 0 30 NA
Philippon et al. 2013 4 10 96 57 41 54 23
Jackson et al. 2014 4 12 54 28.8 2 28.8 18
Krych et al. 2014 4 14 59 46 7 60 Not stated
Nielsen et al. 2014 4 12 117 37 5 Not stated Not stated
Skendzel et al. 2014 4 11 466 39.6 117 73 31.6
(continued)
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Table I. (continued)

















Wilkin et al. 2014 4 12 41 52.7 6 34.8 18.8
Bedard et al. 2015 4 8 1577 Not stated 84 Not stated 12
Cetinkaya et al. 2015 3a 18/24 73 33.5/39.5 3 45.2/47.2 16
Daivajna et al. 2015 4 12 77 43 34 33.6 18
Fiorenino et al. 2015 4 12 38 44.4 2 36 24.3
Krych et al. 2015 3a 19/24 104 41 2 Not stated Not stated
Malviya et al. 2015 4 8 6935 38 680 28.8 16.8
Sansone et al. 2015 4 11 75 47 5 26 Not stated
Sing et al. 2015 4 8 8277 Not stated 720a Not stated Not stated
Capogna et al. 2016 4 12 42 65.8 3 26.4 Not stated
Comba et al. 2016 4 12 42 38 7 91 33
Haefeli et al. 2016 4 10 52 35 2 79 96a
Hermann et al. 2016 4 8 79 48.6 18 32 Not stated
Hufeland et al. 2016 4 10 44 34.3 5 66.3 28
Kremmers et al. 2016 4 8 10 402 41.3 1096 28.8 Not stated
Mardones et al. 2016 4 10 28 63.4 3 52.8 12
Schairer et al. 2016 4 8 7351 43.9 912a Not stated Not stated
Degen et al. 2017 4 8 8267 Not stated 796 Not stated 19.9
Locks et al. 2017 3a 17/24 11 35 0 62 NA
Menge et al. 2017 4 11 145 Not stated 50 Not stated Not stated
Moriya et al. 2017 4 10 23 59 1 28 13
Tjong et al. 2017 4 10 106 38.1 0 37.2 NA
Truntzer et al. 2017 4 8 2581 Not stated 88 Not stated Not stated
Cvetanovich et al. 2018 4 10 474 33.3 7 31.2 Not stated
Domb et al. 2018 4 10 1038 36.4 66 30.1 Not stated
Kaldau et al. 2018 4 10 84 40.4 15 82.9 Not stated
Kester et al. 2018 4 8 3957 35.8 235 Not stated 14.7
Maldonado et al. 2018 2a 16/24 743 27.8/34.1 11 42.5/43.9 38.7/35.1
McCarthy et al. 2018 4 10 989 41.1 210 Not stated Not stated
(continued)
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Evidence
From the 46 papers included in our study, there were: 2
papers of Level 2b, 3 papers of Level 3b and 41 papers of
Level 4 evidence. Mean MINORS score for non-
comparative studies was 9 for non-comparative and 16 for
comparative (Fig. 2).
Key findings
The key findings of the studies along with outcome for
conversion rates to THA are included in Table II. Upon
analysis, there were 4862 hips looked at with 404 that
underwent conversion to THA, giving a percentage con-
version of 8.31% (95% CI 7.54–9.12%). For papers that
Table I. (continued)

















Olach et al. 2018 4 9 92 36 11 134.4 Not stated
Perets et al. 2018 4 10 12 39.9 1 45 24
Philippon et al. 2018 3a 15/24 99 29 4 Not stated 31.25a
Schutler et al. 2018 4 11 529 43.9 63 Not stated Not stated
aValue calculated from data.
Fig. 2. PAO search: PRISMA flowchart.
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Table II. Results for PAO
















Crockerell et al. 1999 4 8 21 Not stated 1 38 Not stated
Davey et al. 1999 4 10 70 Not stated 0 Not stated Not stated
Matta et al. 1999 4 8 66 33.6 5 48 85.2
Mayo et al. 1999 4 6 19 30.9 2 45 18/67
Murphy et al. 1999 3a 12/24 195 29 2 36–94 Not stated
Trumble et al. 1999 4 10 123 32.9 7 51.6 41
Valenzuela et al. 2004 4 8 94 32 2 45.6 Not stated
Kralj et al. 2005 4 10 26 34 4 144 54
Pogliacomi et al. 2005 4 10 32 Not stated 3 48 72
Peters et al. 2006 4 10 83 28 3 46 36
Bernstein et al. 2007 4 16/24 47 20–27 1 228 12
Clohisy et al. 2007 4 10 24 22.7 0 46.8 Not stated
Garras et al. 2007 4 10 58 37.6 4 66.7 36
Badra et al. 2008 4 8 36 27.9 3 42 Not stated




Armiger et al. 2009 4 10 12 35 1 24 36
Matheney et al. 2009 4 10 135 23.9 17 108 73.2
Millis et al. 2009 4 10 87 43.6 21 58.8 62.4
Burke et al. 2011 4 10 85 22.9 4 59 Not stated
Howie et al. 2011 4 10 26 28 3 120 Not stated
Ito et al. 2011 4 10 175 47.2/27.1 7 132 Not stated
Kain et al. 2011 3a 16/24 17/34 31 3 56.4/31.2 169.2a
Ziebarth et al. 2011 4 10 46 23.5 1 43 18
Hartig-Andreasen et al. 2012 4 10 401 33.9 69 96 Not stated
Polkowski et al. 2012 4 8 67 19.2 5 60 79
Sang do Kim et al. 2012 4 10 43 28 5 32 Not stated
Albers et al. 2013 4 8 165 28/29 19 132 Not stated
Tannast et al. 2013 4 6 26 23 7 56.4 Not stated
Zhu et al. 2013 4 10 41 39.5 1 61.2 108
(continued)
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stated mean age, the mean age from these was 30.08 years.
Where papers stated their mean follow-up in a way that
could be analysed; the range was 14–348 months and this
gave a mean follow-up time, for all papers of 85.5 months.
Where papers stated the mean conversion to THA in a
way that could be analysed; the range was 12–192 months,
and this gave a mean conversion time for all papers of
70.11 months.
Only one paper [96] presented data, related to age groups,
in a way that could be analysed. This included 158 patients
comparing those under 40 years of age versus over 40 years of
age. From this paper, there were 4 out of 117 hips (3.42%
[95% CI 9.39–8.52%]) under 40, that PAO and were subse-
quently converted to THA versus 3 out of 38 hips (7.89%
[95% CI 16.59–21.38%]) of patients over 40. On statistical
analysis, this was not statistically significant at P¼ 0.385.
Seven papers [86, 91, 95, 100, 101, 105, 115] looked at
the prevalence of conversion to THA based on their grade
of OA and presented data in a way that could be analysed.
This included 660 patients. In order to standardize arth-
ritis, the authors categorized it as non/mild–moderate and
severe, where Outerbridge (0/1/2), Tonnis (0/1),
Kellegren-Lawrence (0/1/2)—was non/mild–moderate
and Outerbridge (3/4), Tonnis (2/3), Kellegren-Lawrence
(3/4)—was severe. Where authors reported more than
one, Tonnis grade was used preferentially.
From these papers, 74 out of 576 (12.85% [95% CI
10.22–15.86%]) of all patients with non/mild–moderate
OA underwent conversion to THA versus 43 out of 84
(51.19% [95% CI 40.03–62.26%]) of patients with moder-
ate to severe OA. The difference between groups was stat-
istically significant at P< 0.001, suggesting increasing
Table II. (continued)
















Beaulé et al. 2014 4 10 72 32 1 60 86
Bogunovic et al. 2014 4 8 39 25 1 33 27
Dahl et al. 2014 4 12 122 31 11 84 54
Zaltz et al. 2014 4 10 205 25.4 1 14 36
Grammatopoulos et al. 2015 4 10 66 25 4 96 94
Wells et al. 2016 4 8 121 26 26 216 108
Clohisy et al. 2017 4 12 391 25.4 3 31.2 Not stated
Hara et al. 2017 4 8 183 42 4 100 Not stated
Khan et al. 2017 4 10 166 32 2 33.6 20
Lerch et al. 2017 4 9 75 29 42 348 192
Shan Chou et al. 2018 4 10 85 26 6 60 45.5
Grammatopoulus et al. 2018 4 14 244 26 3 48 Not stated
Hamai et al. 2018 4 9 46 47.5 14 202.8 108
Hellman et al. 2018 3a 10 56 31.08/28.61 0 36.0/50.41 NA
Isaksen et al. 2018 4 10 69 32 9 88.8 88.8
Navid et al. 2018 4 9 302 32.7 54 134.4 Not stated
Wells et al. 2018 4 8 154 26 8 123.6 81.6
aValue calculated from data.
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arthritis may be a risk factor for conversion to THA after
PAO.
One paper [115] looked at conversion rates to THA
based on joint space. This included 126 with data for 117
patients. Those with >2 mm joint space, 9 out of 80
(11.25% [95% CI 52.28–20.28%]) underwent conversion
and those with 2 mm, 15 out of 37 (40.54% [95% CI
24.75–57.90%]) underwent conversion. The difference
between groups was statistically significant at P< 0.001
and suggests that reduced joint space may be a risk factor
for conversion to THA after PAO.
D I S C U S S I O N
The association between FAI and OA was the subject of a
recent systematic review [120] and it is clear that despite
the exponential increase in the number of HAs performed
[121], explicit evidence reporting longer-term outcomes
and subsequently supporting long-term success is limited.
We also know that developmental dysplasia of the hip, and
its subsequent structural instability, is known to be a cause
of secondary OA [4, 5]. Arthroscopic intervention is min-
imally invasive and aims to deal with FAI by addressing
congruity of the joint by dealing with cam and/or pincer
pathologies and managing the secondary intra-articular
pathology of labral tear. The PAO on the other hand is a
bigger operation involving an osteotomy of the pelvis to re-
orient the acetabulum, to correct aberrant acetabular
morphology and improve femoral head coverage. The
Bernese group, where Ganz first described the PAO [9],
have published their 20-year follow-up [122] and 30-year
follow-up [101], with the most up to date paper included
in this review article.
While the authors recognize that there are other treat-
ment options available, such as open impingement proce-
dures and alternative osteotomies, HA and PAO are the
most frequently used techniques in the adult population.
The ultimate aim of these procedures is to, both, improve
symptoms that arise from hip joint pathology including
pain, reduced movement/mobility and to preserve the hip
joint of a patient with underlying pathology,
With respect to risk factors for conversion, for HA, age
>40, moderate to severe OA and a joint space of 2 mm
was associated with statistically significant differences in
conversion rates. For PAO, statistically significant differen-
ces in conversion rates were seen when arthritis was mod-
erate to severe and joint space was 2 mm.
A number of studies have shown increasing age to result
in higher conversion rates to joint arthroplasty following
hip preservation surgery [22, 54, 57, 83, 96, 102, 123–
126]. For HA age >40 was demonstrated by Mccarthy
et al. [54] to result in an increased rate of conversion to
THA, whereas Comba et al. [22] identified 45 and
Capogna et al. [20, 127] identified 60. Malviya et al. [49]
have demonstrated in a series of 6395 patients undergoing
hip arthroscopic intervention that the odds of conversion
to THA is 4.65 times higher in patients over the age of 50
compared with under the age of 50. The majority of the lit-
erature, regarding PAO outcomes, pertains to patient
under the age of 40, however, age has been demonstrated
as a risk factor for conversion to THA [83, 102] and where
they are performed in patients over the age of 40, this may
result in increased rates of conversion to THA [92].
As aforementioned arthritis and degenerative features,
in their own right, along with reduced joint space, particu-
larly a joint space of <2 mm [54, 57, 65, 123–125, 128,
129] were also associated with conversion to THA in
arthroscopy and these features were also a predictor shared
by several authors when looking at PAO [78, 84, 86, 88,
99, 108].
Other systematic reviews looking at only HA cohort
have had similar findings to ours. Domb et al. [130] in a
13 paper systematic review, looking at the outcomes of
HA, noted that there was a significantly higher conversion
rate to THA in the presence of established arthritis, with
8.3% of patients requiring hip arthroplasty in the non-OA
group, versus 23% requiring conversion to THA in the
arthritic group, with a mean time to conversion of
26 months and 17.1 months, respectively (P< 0.01).
Another review by Kemp et al. [131], looking at HA in
the context of OA, noted that the progression to THR
post-arthroscopy ranged from 7 months to 4.8 years.
Regarding PAO, Clohisy et al.’s review found [132] that
clinical failures were commonly associated with moderate
to severe pre-operative OA and conversion to THA was
reported in 0–17% of cases. Major complications were
noted in 6–37% of the procedures. These data indicate
that PAO provides pain relief and improved hip function
in most patients over short- to mid-term follow-up. The
current evidence is primarily Level 4.
It is evident, from the size of the studies included in this
review, that larger studies of better quality are required to
evaluate the usefulness of these procedures with a mean
sample size of 958 from the HA studies and 107 for the
PAO studies. The quality of the papers was also poor, high-
lighted by their MINORS scores and the lack of Level 1
and Level 2 evidence. However, the results of this paper
are certainly suggestive of the fact that joint preservation
surgery can be an efficacious way of addressing young adult
hip pathology and preserving the hip joint in the short to
medium term. The authors feel that an effective way to
analyse large amounts of data is to look at population-
based studies, such as the largest study in our series by
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Malviya et al. [49] which looked at HA in 6395 patients
with a median 2.4-year follow-up (range: 0.5–8.2 years).
This demonstrated a survival analysis over an 8-year
period, with an 82.6% survival rate and a THA rate of 680
patients (10.6%) with a mean time to conversion of
1.4 years. Malviya et al.’s findings for HA are aligned with
the findings of our study. Hartig-Andreasen et al.’s series,
which was the largest of the PAO papers [92], which
included 401 hips, reported 69 hips converted to THR at
3.9–12.4 years following the PAO. The overall Kaplan–
Meier hip survival rate was 74.8% at 12.4 years.
The authors propose that larger studies can be achieved
through the use of procedure registries and a number of
the HA papers were able to report larger numbers due to
registry use. In the UK, the Non-Arthroplasty Hip Registry
is established, aiming to capture all operations around the
hip which are not arthroplasty or for acute trauma. With
patient compliance to follow-up being a barrier to good
quality mid- to long-term studies, having a registry and fur-
ther developing an infrastructure to facilitate such follow-
up may provide useful data to improve surgical practise.
While there is benefit in knowing the results of surgery by
individual surgeons, like the majority of papers in this re-
view, there is an inherent risk of publication bias, with
most studies being performed, reported, cited and pub-
lished by high-volume surgeons. Population-based studies
help us understand and explore the results in ‘non-expert’
hands.
There are also other significant limitations of this study.
The papers are included are incredibly heterogeneous with
no standardization of operative intervention or post-
operative rehabilitation, potentially giving significant vari-
ability in results. It does also not consider the functional
outcomes and purely looks at conversion rate, using con-
version to THA as a surrogate for success or failure.
Clearly the issue is a more complex one, with not all fail-
ures undergoing conversion. Furthermore, when looking at
risk factors for conversions, few papers presented raw data
in a way that could be analysed, detracting from statistical
analysis. When considering what patients want, one would
assume that their main desires are to be pain free and have
good function. The potential importance of patients keep-
ing one’s hip joint is important to health services and clini-
cians; to limit technically demanding revision procedures
and the potential complications associated with arthro-
plasty, as well as quelling the economic burden of arthro-
plasty, however, the importance of hip joint preservation
to patients are unknown and the authors feel there should
be more evidence on functional outcomes for joint preser-
vation surgery, ideally building on the information gleaned
from the UK FASHiON trial [133] and, ongoing FAIT
trial [134], through sufficiently powered randomized con-
trol trials comparing non-operative management to joint
preservation surgery.
We have focused on the conversion to THA in this
study and when considering this factor, the results appear
favourable, in the short to medium term at least, when one
considers that <10% of patients are undergoing conver-
sion. More long-term evidence is available for PAOs com-
pared with HAs but clearly more robust evidence will be
required to strengthen the argument in favour of hip-
preserving surgery. The findings do, however, highlight
that patient selection is crucial to achieving good
outcomes.
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